Clinilabs
Research ServicesNew Jersey, United States201-500 Employees
Clinilabs is a global, full-service contract research organization that focuses exclusively on central nervous system drug, device, and technology development. The firm manages Phase 1 through Phase 3 trials for psychiatric, neurological, substance use, and rare CNS disorders, drawing on indication-specific expertise, a defined process, and current technology to advance therapies. With more than 25 years of global experience, Clinilabs has completed over 800 CNS clinical trial awards and has more than 30 marketed products across 25+ indications. Based in Eatontown, New Jersey, it serves sponsors seeking CNS-focused clinical development. In 2025, Clinilabs announced leadership additions, appointing David Hagerman as Chief Financial Officer and Jeanine Falinski as Senior Vice President of Commercial Development. These appointments reflect the company's ongoing expansion of its executive team and commercial capabilities.
1-888-653-2347 
support@leadiq.com 
